ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,232.80
0.20%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36405
0.12%
Bitcoin
70,097.62
-1.89%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rigel Pharmaceuticals Inc (RIGL)

  7. Rigel Pharmaceuticals Inc (RIGL) News

RIGL

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RIGL
DateTimeSourceHeadlineSymbolCompany
05/07/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
05/07/20243:01PMPR Newswire (US)Rigel Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
04/30/20247:05AMPR Newswire (US)Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
04/10/20243:30PMPR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
04/04/20247:05AMPR Newswire (US)Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & LymphomaNASDAQ:RIGLRigel Pharmaceuticals Inc
03/12/20247:05AMPR Newswire (US)Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical OfficerNASDAQ:RIGLRigel Pharmaceuticals Inc
03/05/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
03/05/20243:06PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RIGLRigel Pharmaceuticals Inc
03/05/20243:01PMPR Newswire (US)Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/20246:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/20246:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/20246:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
03/01/20246:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/27/20247:05AMPR Newswire (US)Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2023 Financial Results and Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
02/22/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
02/22/20246:50AMPR Newswire (US)Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®NASDAQ:RIGLRigel Pharmaceuticals Inc
02/14/20241:30PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
02/06/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/06/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/06/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
02/02/20248:56AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
01/25/20248:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
01/25/20248:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
01/25/20248:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
01/25/20248:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RIGLRigel Pharmaceuticals Inc
01/25/202412:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RIGLRigel Pharmaceuticals Inc
01/08/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RIGLRigel Pharmaceuticals Inc
01/08/20247:05AMPR Newswire (US)Rigel Pharmaceuticals Provides Business UpdateNASDAQ:RIGLRigel Pharmaceuticals Inc
01/05/20243:30PMPR Newswire (US)Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:RIGLRigel Pharmaceuticals Inc
01/04/20247:05AMPR Newswire (US)Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in GliomaNASDAQ:RIGLRigel Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RIGL

Your Recent History

USOTC
IBGR
Nexus Energy Services (PK)
USOTC
QEDN
QED Connect (PK)
USOTC
WNFT
Worldwide NFT (PK)
USOTC
SRMX
Saddle Ranch Media (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
DPLS
DarkPulse (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
GDVM
Global Developments (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
GGEI
Green Giant (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved